Spinal Tech Archives - Page 851 of 1239

LDR short interest up by 7.8% — 5 quick notes

LDR reported a rise of 92,864 shares or 7.8 percent in the short interest, according to a report by Candle Strips Bar & Graph Report.

IlluminOss Medical's humerus fracture treatment trial enrolls 1st patient

IlluminOss Medical announced that the first patient has been enrolled in its EU Light Fix trial for the treatment of humerus fractures due to metastatic carcinoma.

5 key notes on K2M's stock rating — Now "Strong Buy"

K2M received a new rating score for stocks from four different Zacks brokers, according to a Mideast Times report.

Globus Medical shares price target raised to $30 — 4 quick points

WallachBeth Capital increased their price objective on shares of Globus Medical from $26 to $30, according to a Sleek Money report.

Alphatec Holdings short interest down 0.4% — 5 key updates

Alphatec Holdings, parent company of Alphatec Spine, reported a huge drop in short interest, according to a Candle Strips report.

SI-BONE reaches 15k iFuse procedures — 5 things to know

More than 15,000 procedures with SI-BONE's iFuse Implant System have been performed.

Integra LifeSciences' short interest rises by 2.9%: 5 things to know

Integra LifeSciences reported a rise of 2.9 percent or 55,126 shares in its short interest, according to a report from Candle Strips Bar & Graph Report.

21 spine devices receive FDA 510(k) clearance in February

The Food and Drug Administration granted 21 spine-related devices in February.

Alphatec Spine sees moderate growth of 1.1% for Q4 & full year — 7 key points

Alphatec Holdings, the parent company of Alphatec Spine, announced financial results for the fourth quarter and full year ended Dec. 31, 2014.

NuVasive shares target price raised to $55 by Brean Capital: 4 quick facts

Brean Capital Equities research analysts increased their price objective on NuVasive shares from $53 to $55 in a research note, according to a Dakota Financial News report.